PDLI
PDL BioPharma, Inc. Common Stock
stockNASDAQ
InactiveDec 28, 2020
2.71USD+1.119%(+0.03)2,353,432
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
CEO
John McLaughlin
HQ
Incline village, Nevada, USA
Oct 10, 2001 · 2-for-1
PDLI Profile
PDL BioPharma Inc is engaged in the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing value of its patent.
PDLI Performance
| Period | Price | Date | Change |
|---|